165 related articles for article (PubMed ID: 38005331)
1. Norcantharidin-Encapsulated C60-Modified Nanomicelles: A Potential Approach to Mitigate Cytotoxicity in Renal Cells and Simultaneously Enhance Anti-Tumor Activity in Hepatocellular Carcinoma Cells.
Ding Z; Xu B; Zhang H; Wang Z; Sun L; Tang M; Ding M; Zhang T; Shi S
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005331
[TBL] [Abstract][Full Text] [Related]
2. Preparation and Evaluation of the Cytoprotective Activity of Micelles with DSPE-PEG-C60 as a Carrier Against Doxorubicin-Induced Cytotoxicity.
Xu B; Ding Z; Hu Y; Zhang T; Shi S; Yu G; Qi X
Front Pharmacol; 2022; 13():952800. PubMed ID: 35991873
[TBL] [Abstract][Full Text] [Related]
3. Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo.
Liu MC; Liu L; Wang XR; Shuai WP; Hu Y; Han M; Gao JQ
Int J Nanomedicine; 2016; 11():1395-412. PubMed ID: 27110110
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional self-assembled micelles of galactosamine-hyaluronic acid-vitamin E succinate for targeting delivery of norcantharidin to hepatic carcinoma.
Jiang S; Li M; Hu Y; Zhang Z; Lv H
Carbohydr Polym; 2018 Oct; 197():194-203. PubMed ID: 30007605
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization and anticancer activity of norcantharidin-loaded poly(ethylene glycol)-poly(caprolactone) amphiphilic block copolymer micelles.
Chen SF; Lu WF; Wen ZY; Li Q; Chen JH
Pharmazie; 2012 Sep; 67(9):781-8. PubMed ID: 23016451
[TBL] [Abstract][Full Text] [Related]
6. Norcantharidin combined with ABT-737 for hepatocellular carcinoma: Therapeutic effects and molecular mechanisms.
Ren J; Li G; Zhao W; Lin L; Ye T
World J Gastroenterol; 2016 Apr; 22(15):3962-8. PubMed ID: 27099439
[TBL] [Abstract][Full Text] [Related]
7. Involvement of mitochondrial pathway in NCTD-induced cytotoxicity in human hepG2 cells.
Chang C; Zhu YQ; Mei JJ; Liu SQ; Luo J
J Exp Clin Cancer Res; 2010 Nov; 29(1):145. PubMed ID: 21059274
[TBL] [Abstract][Full Text] [Related]
8. Treatment for Hepatocellular Carcinoma Is Enhanced When Norcantharidin Is Encapsulated in Exosomes Derived from Bone Marrow Mesenchymal Stem Cells.
Liang L; Zhao L; Wang Y; Wang Y
Mol Pharm; 2021 Mar; 18(3):1003-1013. PubMed ID: 33527831
[TBL] [Abstract][Full Text] [Related]
9. Promising positive liver targeting delivery system based on arabinogalactan-anchored polymeric micelles of norcantharidin.
Zhang Z; Yang L; Hou J; Xia X; Wang J; Ning Q; Jiang S
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S630-S640. PubMed ID: 30449176
[TBL] [Abstract][Full Text] [Related]
10. Atg5 siRNA inhibits autophagy and enhances norcantharidin-induced apoptosis in hepatocellular carcinoma.
Xiong X; Wu M; Zhang H; Li J; Lu B; Guo Y; Zhou T; Guo H; Peng R; Li X; Tian Q; Wang Y
Int J Oncol; 2015 Oct; 47(4):1321-8. PubMed ID: 26240015
[TBL] [Abstract][Full Text] [Related]
11. Norcantharidin triggers cell death and DNA damage through S-phase arrest and ROS-modulated apoptotic pathways in TSGH 8301 human urinary bladder carcinoma cells.
Yu CC; Ko FY; Yu CS; Lin CC; Huang YP; Yang JS; Lin JP; Chung JG
Int J Oncol; 2012 Sep; 41(3):1050-60. PubMed ID: 22684608
[TBL] [Abstract][Full Text] [Related]
12. Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis.
Yan Z; Yang K; Tang X; Bi Y; Ding Y; Deng M; Xia D; Zhao Y; Chen T
J Immunol Res; 2022; 2022():3851604. PubMed ID: 35497873
[TBL] [Abstract][Full Text] [Related]
13. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells.
Chen YN; Chen JC; Yin SC; Wang GS; Tsauer W; Hsu SF; Hsu SL
Int J Cancer; 2002 Jul; 100(2):158-65. PubMed ID: 12115564
[TBL] [Abstract][Full Text] [Related]
14. [Inhibitory effect of norcantharidin combined with evodiamine on the growth of human hepatic carcinoma cell line HepG2 in vitro].
Liu Y; Zahng J; You Z; Liao H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):824-8. PubMed ID: 25108435
[TBL] [Abstract][Full Text] [Related]
15. N-trimethyl chitosan nanoparticle-encapsulated lactosyl-norcantharidin for liver cancer therapy with high targeting efficacy.
Guan M; Zhou Y; Zhu QL; Liu Y; Bei YY; Zhang XN; Zhang Q
Nanomedicine; 2012 Oct; 8(7):1172-81. PubMed ID: 22321383
[TBL] [Abstract][Full Text] [Related]
16. Norcantharidin-induced apoptosis is via the extracellular signal-regulated kinase and c-Jun-NH2-terminal kinase signaling pathways in human hepatoma HepG2 cells.
Chen YN; Cheng CC; Chen JC; Tsauer W; Hsu SL
Br J Pharmacol; 2003 Oct; 140(3):461-70. PubMed ID: 12970086
[TBL] [Abstract][Full Text] [Related]
17. Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery.
Wang Q; Zhang L; Hu W; Hu ZH; Bei YY; Xu JY; Wang WJ; Zhang XN; Zhang Q
Nanomedicine; 2010 Apr; 6(2):371-81. PubMed ID: 19699319
[TBL] [Abstract][Full Text] [Related]
18. Metal-organic framework IRMOFs coated with a temperature-sensitive gel delivering norcantharidin to treat liver cancer.
Li XY; Guan QX; Shang YZ; Wang YH; Lv SW; Yang ZX; Wang R; Feng YF; Li WN; Li YJ
World J Gastroenterol; 2021 Jul; 27(26):4208-4220. PubMed ID: 34326620
[TBL] [Abstract][Full Text] [Related]
19. Regulation of demethylation and re-expression of RASSF1A gene in hepatocellular carcinoma cell lines treated with NCTD in vitro.
Wang Y; Xu M; Di ZH; Zhang J; Mao XQ; Sun HB
J Cancer Res Ther; 2015; 11(4):818-22. PubMed ID: 26881524
[TBL] [Abstract][Full Text] [Related]
20. [Molecular mechanism of norcantharidin inducing apoptosis in liver cancer cells].
Li GQ; Zhang SJ; Lü JF; Wu Y; Li J; Zhang G; Yu JT
Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(30):2145-8. PubMed ID: 21029633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
